- Home
- ETON vs COFS Comparison
ETON vs COFS Comparison
Compare ETON & COFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ETON | COFS |
|---|---|---|
| Founded | 2017 | 1898 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 411.9M | 443.5M |
| IPO Year | 2018 | 1995 |
Fundamental Metrics
Financial Performance| Metric | ETON | COFS |
|---|---|---|
| Price | $19.02 | $27.72 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 2 |
| Target Price | $31.00 | ★ $36.00 |
| AVG Volume (30 Days) | ★ 294.8K | 87.8K |
| Earning Date | 01-01-0001 | 05-01-2026 |
| Dividend Yield | N/A | ★ 4.19% |
| EPS Growth | N/A | ★ 15.25 |
| EPS | N/A | ★ 1.05 |
| Revenue | $39,011,000.00 | ★ $139,099,000.00 |
| Revenue This Year | $107.23 | $21.87 |
| Revenue Next Year | $29.72 | $4.47 |
| P/E Ratio | ★ N/A | $26.37 |
| Revenue Growth | ★ 23.29 | 22.14 |
| 52 Week Low | $11.09 | $24.89 |
| 52 Week High | $23.00 | $33.58 |
Technical Indicators
Market Signals| Indicator | ETON | COFS |
|---|---|---|
| Relative Strength Index (RSI) | 66.47 | 38.87 |
| Support Level | $16.04 | $26.10 |
| Resistance Level | $20.01 | $30.68 |
| Average True Range (ATR) | 1.09 | 0.95 |
| MACD | 0.05 | -0.16 |
| Stochastic Oscillator | 75.56 | 20.65 |
Price Performance
Historical ComparisonAbout ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About COFS ChoiceOne Financial Services Inc.
ChoiceOne Financial Services Inc is a full-service banking institution. It is engaged in the business of providing personal and business banking solutions, borrowing solutions, and treasury notes and bonds services. The bank's product and services portfolio consist of time, savings and demand deposits, safe deposit services, automated transaction machine services, commercial and consumer loans, commercial lending to business, industry, agricultural, construction, inventory, and real estate categories. Its primary market area is Kent, Muskegon, Newaygo, and Ottawa counties in western Michigan, and Lapeer, Macomb, and St. Clair counties in southeastern Michigan in the communities where the Bank's respective offices are located.